239 related articles for article (PubMed ID: 24113835)
1. Risk stratification in arrhythmogenic right ventricular cardiomyopathy.
Silvano M; Corrado D; Köbe J; Mönnig G; Basso C; Thiene G; Eckardt L
Herzschrittmacherther Elektrophysiol; 2013 Dec; 24(4):202-8. PubMed ID: 24113835
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Yin K; Ding L; Li Y; Hua W
Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
[TBL] [Abstract][Full Text] [Related]
6. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
[TBL] [Abstract][Full Text] [Related]
7. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
8. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
Calkins H; Corrado D; Marcus F
Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
[TBL] [Abstract][Full Text] [Related]
9. Management of arrhythmogenic right ventricular cardiomyopathy.
Silvano M; Mastella G; Zorzi A; Migliore F; Pilichou K; Bauce B; Rigato I; Perazzolo Marra M; Iliceto S; Thiene G; Basso C; Corrado D
Minerva Med; 2016 Aug; 107(4):194-216. PubMed ID: 27186923
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
Bosman LP; Te Riele ASJM
Heart; 2022 Jan; 108(2):90-97. PubMed ID: 33990412
[TBL] [Abstract][Full Text] [Related]
12. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
[TBL] [Abstract][Full Text] [Related]
14. Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy.
Yin K; Ding L; Hua W; Zhang S
Pacing Clin Electrophysiol; 2017 Jun; 40(6):683-692. PubMed ID: 28261825
[TBL] [Abstract][Full Text] [Related]
15. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
[TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
[TBL] [Abstract][Full Text] [Related]
17. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
[TBL] [Abstract][Full Text] [Related]
18. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
[TBL] [Abstract][Full Text] [Related]
19. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
[TBL] [Abstract][Full Text] [Related]
20. Arrhythmogenic right ventricular cardiomyopathy: diagnosis and risk stratification.
Boldt LH; Haverkamp W
Herz; 2009 Jun; 34(4):290-7. PubMed ID: 19575159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]